FDA halts Amgen study after teen patient death
Federal health regulators say they have halted Amgen's studies of its thyroid drug Sensipar after the death of a 14-year-old patient in a company trial.
Tags:
FDA halts Amgen study after teen patient death,
Amgen Latest News